Taipei, Taiwan In 1962 was created Cathay Life Insurance, which is appeared as Corporate Investor. The fund was located in Asia if to be more exact in Taiwan. The main office of represented Corporate Investor is situated in the Taipei.
Among the various public portfolio startups of the fund, we may underline TaiGen Biotechnology For fund there is a match between the country of its foundation and the country of its the most frequent investments - Taiwan. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Pharmaceutical, Biotechnology.
The top activity for fund was in 2004. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year.
The usual cause for the fund is to invest in rounds with 7 partakers. The meaningful sponsors for the fund in investment in the same round are YFY Inc., Shin Kong Life Insurance, Major Series A. In the next rounds fund is usually obtained by YFY Inc., YFY Biotech Management Company, Taiwan Sugar Corporation.
Related Funds
| Fund Name | Location |
| Berytech | Beirut, Beirut Governorate, Lebanon |
| Clarendon Fund Managers | Belfast, Northern Ireland, United Kingdom |
| Esas Ventures | Istanbul, Istanbul, Turkey |
| FinTLV Ventures | Israel, Tel Aviv, Tel Aviv |
| Gaas Labs | California, Los Altos Hills, United States |
| Galaxy Digital LP | New York, New York, United States |
| Hankyu Hanshin | Japan, Osaka, Osaka Prefecture |
| IDC Frontier | Japan, Tokyo |
| M&S Partners | Calebasses, Mauritius, Pamplemousses |
| MD Capital | Baltimore, Maryland, United States |
| Mindful Partners | California, Mill Valley, United States |
| Myca Partners | New York, New York, United States |
| Pine Crest Capital | - |
| Redcrest Enterprises | - |
| Rules-Based Medicine | Austin, Texas, United States |
| Smurfit Venture Fund | - |
| T.C.L. Industries Holdings | China, Hong Kong, New Territories |
| Turbo Capital | Beijing, Beijing, China |
| Valent Group | California, San Francisco, United States |
| Wasp Ventures | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
TaiGen Biotechnology | $38M | 16 Mar 2004 | New Taipei, Taiwan |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
TaiGen Biotechnology | $38M | 16 Mar 2004 | New Taipei, Taiwan |
